drugset / Trial / NCT01019408
Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan
Phase 4
Completed
163 enrolled
London School of Hygiene and Tropical Medicine
European Union · collabUnited Nations High Commissioner for Refugees · collabWorld Health Organization · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to provide stronger evidence for extended-dose chloroquine treatment of falciparum-positive Afghan refugees in Northwest Frontier Province (NWFP), Pakistan or justification for discontinuation of the policy.
Timeline
- Start
- 1993-11
- Primary completion
- 1995-01
- Completion
- 1995-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Chloroquine | Small molecule | 25 mg/kg | — |
| Comparator | Chloroquine | Small molecule | 40 mg/kg | — |